Joshua Trae Hampton

Joshua Trae Hampton

Auto-generated profile, based on publicly available information

Joshua Trae Hampton

Texas A&M Drug Discovery Center and Department of Chemistry

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2024 in Chemical Reviews
Verified
Journal Article
Open access
JHJ. Trae Hampton
J. Trae Hampton
WLWenshe Ray Liu
Wenshe Ray Liu
Sitting on the interface between biologics and small molecules, peptides represent an emerging class of therapeutics. Numerous techniques have been developed in the past 30 years to take advantage of biological methods to generate and screen peptide libraries for the identification of therapeutic compounds, with phage display being one of the most accessible techniques. Although traditional phage display can generate billions of peptides simultaneously, it is limited to expression of canonical amino acids. Recently, several groups have successfully undergone efforts to apply genetic code expansion to introduce noncanonical amino acids (ncAAs) with novel reactivities and chemistries into phage-displayed peptide libraries. In addition to biological methods, several different chemical approaches have also been used to install noncanonical motifs into phage libraries. This review focuses on these recent advances that have taken advantage of both biological and chemical means for diversification of phage libraries with ncAAs.

13 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
JTJeffery M. Tharp
Jeffery M. Tharp
JHJ. Trae Hampton
J. Trae Hampton
CRCatrina A. Reed
Catrina A. Reed
AEAndreas Ehnbom
Andreas Ehnbom
PCPeng-Hsun Chase Chen
Peng-Hsun Chase Chen
WLWenshe Ray Liu
Wenshe Ray Liu
Although noncanonical amino acids (ncAAs) were first incorporated into phage libraries through amber suppression nearly two decades ago, their application for use in drug discovery has been limited due to inherent library bias towards sense-containing phages. Here, we report a technique based on superinfection immunity of phages to enrich amber-containing clones, thus avoiding the observed bias that has hindered incorporation of ncAAs into phage libraries. We then take advantage of this technique for development of active site-directed ligand evolution of peptides, where the ncAA serves as an anchor to direct the binding of its peptides to the target’s active site. To demonstrate this, phage-displayed peptide libraries are developed that contain a genetically encoded butyryl lysine and are subsequently used to select for ligands that bind SIRT2. These ligands are then modified to develop low nanomolar inhibitors of SIRT2.

29 September 2022 in ACS Chemical Biology
Verified
Journal Article
Closed access
JHJ. Trae Hampton
J. Trae Hampton
TLTyler J. Lalonde
Tyler J. Lalonde
JTJeffery M. Tharp
Jeffery M. Tharp
YKYadagiri Kurra
Yadagiri Kurra
YAYugendar R. Alugubelli
Yugendar R. Alugubelli
WLWenshe Ray Liu
Wenshe Ray Liu

27 February 2024 in ACS Central Science
Verified
Journal Article
Open access
PCPeng-Hsun Chase Chen
Peng-Hsun Chase Chen
XGXuejiao Shirley Guo
Xuejiao Shirley Guo
HZHanyuan Eric Zhang
Hanyuan Eric Zhang
GDGopal K. Dubey
Gopal K. Dubey
ZGZhi Zachary Geng
Zhi Zachary Geng
WLWenshe Ray Liu
Wenshe Ray Liu
Epigenetic reader proteins interpret histone epigenetic marks to regulate gene expression. Given their vital roles and the link between their dysfunction and various diseases, these proteins present compelling targets for therapeutic interventions. Nevertheless, designing selective inhibitors for these proteins poses significant challenges, primarily due to their unique properties such as shallow binding sites and similarities with homologous proteins. To overcome these challenges, we propose an innovative strategy that uses phage display with a genetically encoded noncanonical amino acid (ncAA) containing an epigenetic mark. This ncAA guides binding to the reader protein’s active site, allowing the identification of peptide inhibitors with enhanced affinity and selectivity. In this study, we demonstrate this novel approach’s effectiveness by identifying potent inhibitors for the ENL YEATS domain that plays a critical role in leukemogenesis. Our strategy involved genetically incorporating Nε-butyryl-l-lysine (BuK), known for its binding to ENL YEATS, into a phage display library for enriching the pool of potent inhibitors. One resultant hit was further optimized by substituting BuK with other pharmacophores to exploit a unique π–π–π stacking interaction with ENL YEATS. This led to the creation of selective ENL YEATS inhibitors with a KD value of 2.0 nM and a selectivity 28 times higher for ENL YEATS than its close homologue AF9 YEATS. One such inhibitor, tENL-S1f, demonstrated robust cellular target engagement and on-target effects to inhibit leukemia cell growth and suppress the expression of ENL target genes. As a pioneering study, this work opens up extensive avenues for the development of potent and selective peptidyl inhibitors for a broad spectrum of epigenetic reader proteins.

7 January 2025 in ACS Chemical Biology
Verified
Journal Article
Open access
JHJ. Trae Hampton
J. Trae Hampton
CDConnor R. Dobie
Connor R. Dobie
DCDemonta D. Coleman
Demonta D. Coleman
MCMoulay I. Cherif
Moulay I. Cherif
SDSukant Das
Sukant Das
WLWenshe Ray Liu
Wenshe Ray Liu
Current methods for the macrocyclization of phage-displayed peptides often rely on small molecule linkers that nonspecifically react with targeted amino acid residues. To expand tool kits for more regioselective macrocyclization of phage-displayed peptides, this study explores the unique condensation reaction between an N-terminal cysteine and nitrile along with the reactivity of an internal cysteine. Five 2-cyanopyrimidine derivatives were synthesized for this purpose and evaluated for their selective macrocyclization of a protein-fused model peptide. Among these, two novel linkers, 2-chloro-N-(2-cyanopyrimidin-5-yl)acetamide (pCAmCP) and 2-chloro-N-(2-cyanopyrimidin-4-yl)acetamide (mCAmCP), emerged as efficient molecules and were demonstrated to macrocyclize phage-displayed peptide libraries flanked by an N-terminal and an internal cysteine. Using these linkers to generate macrocyclic peptide libraries displayed on phages, peptide ligands for the ZNRF3 extracellular domain were successfully identified. One of the identified peptides, Z27S1, exhibited potent binding to ZNRF3 with a KD value of 360 nM. Notably, the selection results revealed distinct peptide enrichment patterns depending on whether mCAmCP or pCAmCP was used, underscoring the significant impact of linker choice on macrocyclic peptide identification. Overall, this study validates the development of two novel regioselective, small molecule linkers for phage display of macrocyclic peptides and highlights the benefits of employing multiple linkers during phage selections.

28 November 2022 in Protein Science
Verified
Journal Article
Closed access
JMJared S. Morse
Jared S. Morse
YSYan J. Sheng
Yan J. Sheng
JHJoshua Trae Hampton
Joshua Trae Hampton
LSLauralee D. Sylvain
Lauralee D. Sylvain
SDSukant Das
Sukant Das
WLWenshe Ray Liu
Wenshe Ray Liu